Genomics into health
As genomic experts, we have a comprehensive understanding of how innovative technologies can contribute to more effective healthcare
We work with policy-makers, clinicians, academia and industry to develop future-focused healthcare strategies for safe and suitable use of innovations, such as diagnostics, genome editing and regenerative medicines. Only through understanding the benefits - and complexities - of genomics-based innovations and other 'omics sciences can we help everyone benefit from great science.
Report Control of patient information in the COVID-19 era
The control of patient information (COPI) notices have had significant positive impacts on COVID-19 - related research, but the success of future reforms to the use of CPI relies on building trustworthiness.
Policy briefing CAR-T cell therapies
CAR-T cell therapies are a form of cellular immunotherapy that use genetically modified T cells, a type of white blood cell.
Blog Using genomics to improve drug prescribing
4 April 2022
A recent joint report has outlined guidance, barriers and opportunities around the use of pharmacogenomics.
Report Our healthy future
What do we want our healthy future to look like, and how can we ensure science helps our path towards that future?
Blog Host genomics beyond the pandemic
8 July 2022
Host genomics has been a central player in the various approaches to untangle the complex biology of COVID-19.
Blog Bringing diversity to the reference genome
7 June 2022
A person’s genome has over 6 billion base pairs. Small differences in those genomes play a role in making each individual unique, including their health.
Blog Goldacre recommendations for making the most of health data for research
8 April 2022
The Goldacre review, 'Better, broader, safer: using health data for research and analysis' is a hard-hitting report with recommendations for enabling the proper use of NHS health and care data for research , to drive improvements in health and care
Blog Urgent policy priorities for cancer
7 April 2022
The House of Commons Health and Social Care Committee released a report warning NHS targets for early diagnosis of cancer will not be met.
Explainer Vaccinomics
1 November 2021
What is vaccinomics?
Report Control of patient information in the COVID-19 era
25 October 2021
The control of patient information (COPI) notices have had significant positive impacts on COVID-19 - related research, but the success of future reforms to the use of CPI relies on building trustworthiness.
Blog Host genomics and COVID-19: where are we now?
25 October 2021
COVID-19 can have severe effects on even apparently low-risk individuals, and it has become clear that host factors affecting the risk of infection and disease progression include genomics.